News from NORD

FDA Commissioner to Present Keynote Address at NORD Summit


 

Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, will present the keynote address in the opening session of the 2017 NORD Summit. Dr. Gottlieb, who was sworn in as FDA Commissioner in May 2017, previously served as FDA’s Deputy Commissioner for Medical and Scientific Affairs. Before that, he was Senior Adviser to the FDA Commissioner.

Mike Porath, award-winning journalist and founder/CEO of The Mighty, will present the patient keynote. He has held writing, editing, and executive positions at ABC News, NBC News, the New York Times, and AOL. Mr. Porath is the father of a child with Dup15q syndrome and sits on the board of Dup15q Alliance.

Recommended Reading

Neurologists Review the Data on Treatments for Spinocerebellar Ataxias
MDedge Neurology
Gene therapy for spinal muscular atrophy shows promise in early study
MDedge Neurology
Course and outcome of Guillain-Barré syndrome measured in ongoing study
MDedge Neurology
First Clinical Trial of a Genetic Therapy for Huntington’s Disease Nears Completion
MDedge Neurology
How Often Are EEGs Overread?
MDedge Neurology
Studies support early use of genetic tests in early childhood disorders
MDedge Neurology
How Can Neurologists Help Manage Symptoms in Patients With ALS?
MDedge Neurology
How to Keep Pace With Genetic Advances in Movement Disorders
MDedge Neurology
Screening MRI misses Sturge-Weber in babies with port-wine stain
MDedge Neurology
Preview Agenda for NORD’s 2017 Rare Diseases and Orphan Products
MDedge Neurology